Christopher P. Prior serves as Executive at INNOVATE BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Christopher P. Prior has executed 5 insider transactions totaling $24.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 29, 2018 involved purchasing 5,000 shares valued at $13.8K.
Christopher P. Prior currently holds 7,009 shares of INNOVATE BIOPHARMACEUTICALS, INC. (INNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher P. Prior has been a net buyer of INNT stock. They have purchased $24.5K and sold $0 worth of shares.
Christopher P. Prior's most recent insider trade was on Nov 29, 2018, when they purchased 5,000 shares at $2.75 per share.
Get notified when new Form 4 filings are submitted
| $5.82 |
| Discretionary |
| Sep 12, 2018 | INNT | $3.1K | Purchase | 500 | $6.13 | Discretionary |
| Aug 30, 2018 | INNT | $1.6K | Purchase | 309 | $5.20 | Discretionary |
| Aug 28, 2018 | INNT | $4.9K | Purchase | 1,000 | $4.93 | Discretionary |